Document is current
Any future updates will be listed below
-
Authors
Lin, Xin
Provasi, Davide https://orcid.org/0000-0002-2868-303X
Niswender, Colleen M.
Asher, Wesley B. https://orcid.org/0000-0001-7437-218X
Javitch, Jonathan A. https://orcid.org/0000-0001-7395-2967
-
Funding
Funding for this research was provided by:
Hope for Depression Research Foundation (N/A)
- License Information
-
More Information
Article History
Received: 2 January 2024
Accepted: 20 September 2024
First Online: 3 October 2024
Competing interests
: C.N. has received research support from Boehringer Ingelheim and Acadia Pharmaceuticals and has an equity interest in Appello Pharmaceuticals. The Boehringer Ingelheim and Acadia programs are focused on distinct targets to those explored here. Appello Pharmaceuticals licensed an mGlu<sub>4</sub> PAM from Vanderbilt, but the mGlu<sub>4</sub> compounds used in this paper are all in the public domain. The remaining authors declare no competing interests.
